367 related articles for article (PubMed ID: 36080483)
1. Plumbagin Suppresses Breast Cancer Progression by Downregulating HIF-1α Expression via a PI3K/Akt/mTOR Independent Pathway under Hypoxic Condition.
Jampasri S; Reabroi S; Tungmunnithum D; Parichatikanond W; Pinthong D
Molecules; 2022 Sep; 27(17):. PubMed ID: 36080483
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory interferon activates HIF-1α-mediated epithelial-to-mesenchymal transition via PI3K/AKT/mTOR pathway.
Yeh YH; Hsiao HF; Yeh YC; Chen TW; Li TK
J Exp Clin Cancer Res; 2018 Mar; 37(1):70. PubMed ID: 29587825
[TBL] [Abstract][Full Text] [Related]
3. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
4. Rapid non-genomic signalling by 17β-oestradiol through c-Src involves mTOR-dependent expression of HIF-1α in breast cancer cells.
Sudhagar S; Sathya S; Lakshmi BS
Br J Cancer; 2011 Sep; 105(7):953-60. PubMed ID: 21897387
[TBL] [Abstract][Full Text] [Related]
5. Celecoxib Down-Regulates the Hypoxia-Induced Expression of HIF-1α and VEGF Through the PI3K/AKT Pathway in Retinal Pigment Epithelial Cells.
Sun YZ; Cai N; Liu NN
Cell Physiol Biochem; 2017; 44(4):1640-1650. PubMed ID: 29216640
[TBL] [Abstract][Full Text] [Related]
6. Sirolimus increases the anti-cancer effect of Huai Er by regulating hypoxia inducible factor-1α-mediated glycolysis in hepatocellular carcinoma.
Zhou L; Zhao Y; Pan LC; Wang J; Shi XJ; Du GS; He Q
World J Gastroenterol; 2022 Aug; 28(32):4600-4619. PubMed ID: 36157928
[TBL] [Abstract][Full Text] [Related]
7. Akt1 activation can augment hypoxia-inducible factor-1alpha expression by increasing protein translation through a mammalian target of rapamycin-independent pathway.
Pore N; Jiang Z; Shu HK; Bernhard E; Kao GD; Maity A
Mol Cancer Res; 2006 Jul; 4(7):471-9. PubMed ID: 16849522
[TBL] [Abstract][Full Text] [Related]
8. Effect of Glut-1 and HIF-1α double knockout by CRISPR/CAS9 on radiosensitivity in laryngeal carcinoma via the PI3K/Akt/mTOR pathway.
Bao YY; Zhong JT; Shen LF; Dai LB; Zhou SH; Fan J; Yao HT; Lu ZJ
J Cell Mol Med; 2022 May; 26(10):2881-2894. PubMed ID: 35415942
[TBL] [Abstract][Full Text] [Related]
9. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression.
Laughner E; Taghavi P; Chiles K; Mahon PC; Semenza GL
Mol Cell Biol; 2001 Jun; 21(12):3995-4004. PubMed ID: 11359907
[TBL] [Abstract][Full Text] [Related]
10. 12-Deoxyphorbol 13-palmitate inhibits the expression of VEGF and HIF-1α in MCF-7 cells by blocking the PI3K/Akt/mTOR signaling pathway.
Yang Y; Cong H; Han C; Yue L; Dong H; Liu J
Oncol Rep; 2015 Oct; 34(4):1755-60. PubMed ID: 26239613
[TBL] [Abstract][Full Text] [Related]
11. A group of novel HIF-1α inhibitors, glyceollins, blocks HIF-1α synthesis and decreases its stability via inhibition of the PI3K/AKT/mTOR pathway and Hsp90 binding.
Lee SH; Jee JG; Bae JS; Liu KH; Lee YM
J Cell Physiol; 2015 Apr; 230(4):853-62. PubMed ID: 25204544
[TBL] [Abstract][Full Text] [Related]
12. 1,2,3,4,6-Penta-O-galloly-beta-D-glucose suppresses hypoxia-induced accumulation of hypoxia-inducible factor-1α and signaling in LNCaP prostate cancer cells.
Park KY; Lee HJ; Jeong SJ; Lee HJ; Kim HS; Kim SH; Lim S; Kim HC; Lü J; Kim SH
Biol Pharm Bull; 2010; 33(11):1835-40. PubMed ID: 21048308
[TBL] [Abstract][Full Text] [Related]
13. Gambogic acid suppresses hypoxia-induced hypoxia-inducible factor-1α/vascular endothelial growth factor expression via inhibiting phosphatidylinositol 3-kinase/Akt/mammalian target protein of rapamycin pathway in multiple myeloma cells.
Wang F; Zhang W; Guo L; Bao W; Jin N; Liu R; Liu P; Wang Y; Guo Q; Chen B
Cancer Sci; 2014 Aug; 105(8):1063-70. PubMed ID: 24890366
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
Gong T; Cui L; Wang H; Wang H; Han N
J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
[TBL] [Abstract][Full Text] [Related]
15. Ascofuranone suppresses EGF-induced HIF-1α protein synthesis by inhibition of the Akt/mTOR/p70S6K pathway in MDA-MB-231 breast cancer cells.
Jeong YJ; Cho HJ; Magae J; Lee IK; Park KG; Chang YC
Toxicol Appl Pharmacol; 2013 Dec; 273(3):542-50. PubMed ID: 24096035
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonates suppress insulin-like growth factor 1-induced angiogenesis via the HIF-1alpha/VEGF signaling pathways in human breast cancer cells.
Tang X; Zhang Q; Shi S; Yen Y; Li X; Zhang Y; Zhou K; Le AD
Int J Cancer; 2010 Jan; 126(1):90-103. PubMed ID: 19569175
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of Hypoxia-Inducible Factor 1α (HIF-1α) Promotes Autophagy and Inhibits Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Ovarian Cancer Cells.
Huang J; Gao L; Li B; Liu C; Hong S; Min J; Hong L
Med Sci Monit; 2019 Jun; 25():4250-4263. PubMed ID: 31175269
[TBL] [Abstract][Full Text] [Related]
18. HIF-1α mediates CXCR4 transcription to activate the AKT/mTOR signaling pathway and augment the viability and migration of activated B cell-like diffuse large B-cell lymphoma cells.
Jin Z; Xiang R; Dai J; Wang Y; Xu Z
Mol Carcinog; 2023 May; 62(5):676-684. PubMed ID: 36789975
[TBL] [Abstract][Full Text] [Related]
19. HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs).
De Francesco EM; Lappano R; Santolla MF; Marsico S; Caruso A; Maggiolini M
Breast Cancer Res; 2013; 15(4):R64. PubMed ID: 23947803
[TBL] [Abstract][Full Text] [Related]
20. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
